Novo Nordisk's Innovation Supports a Wide Moat and GLP-1 Market Growth
We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...
LifeVantage reports positive results from GLP-1 study
SALT LAKE CITY - LifeVantage Corporation (NASDAQ:LFVN), a $271 million market cap player in the health and wellness sector with impressive 79% gross profit margins, today announced the successful ...
Can Ozempic face be fixed naturally? Easy ways to avoid skin sagging
Rapid fat loss from GLP-1 medications like Ozempic can lead to 'Ozempic face', characterized by hollow cheeks and sagging ...
Rolling Out1d
The weight loss drug dilemma no one wants to talk about
GLP-1 drugs like Ozempic and Wegovy revolutionized weight loss, but their high cost keeps them out of reach for most ...
The Hain Celestial Group, Inc. (HAIN) Q2 2025 Earnings Call Transcript
The Hain Celestial Group, Inc. ( NASDAQ: HAIN) Q2 2025 Earnings Conference Call February 10, 2025 8:00 AM ET Alexis Tessier - VP, IR Wendy Davidson - President & CEO Lee Boyce - CFO ...
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...
Le Lézard6d
AAFPRS REVEALS NEW STATISTICS AND TRENDS IN FACIAL PLASTIC SURGERY
The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), the world's largest association of facial plastic and reconstructive surgeons, has released its highly anticipated 2024 ...
Worcester Telegram on MSN6d
Massachusetts health care reaching ‘limits of affordability,’ insurers say
Confronting soaring health care costs compounded by widespread obstacles in accessing care, top insurance executives warned ...
Health.com on MSN10h
Collagen vs. Whey: Which Protein Is Best for Muscles and Skin?
Collagen's amino acids make it better for skin and joint health, while whey protein is a complete protein that can support ...
Lilly's Growth in Diabetes and Obesity, and Strong Oncology and Immunology Drugs Create a Wide Moat
Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...
Jacobs Engineering Group Inc. (NYSE:J) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Call Transcript February 4, 2025 Jacobs Engineering Group Inc. misses on earnings expectations. Reported EPS ...